We planned a study to evaluate the role of T. arjuna in ischemic mitral regurgitation (IMR) following acute myocardial infarction (AMI). 40 patients with fresh AMI showing IMR were randomly divided into 2 groups of 20 each. They were given placebo or 500 mg of T. arjuna in addition to anti-ischemic treatment. After 1 and 3 months of follow up, patients receiving adjuvant T. arjuna showed significant decrease in IMR, improvement in E/A ratio and considerable reduction in anginal frequency.

Arjuna

Health conditions analyzed in this study

Mitral Regurgitation

1 supplement Slightly Positive Arjuna

Functions related to this study

Heart health

1 supplement Slightly Positive Arjuna

---

Body systems related to this study

Cardiovascular System

1 supplement Arjuna